ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Allorecognition"

  • 2016 American Transplant Congress

    Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.

    F. Shihab, B. Kaplan, K. McCague, D. Patel, F. Vincenti.

    University of Utah, Salt Lake City; Mayo Clinic, Phoenix; Novartis Pharmaceuticals Corporation, East Hanover; University of California, San Francisco.

    The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior compared to CellCept®, (mycophenolate…
  • 2016 American Transplant Congress

    miR-21 in Chronic Allograft Vasculopathy.

    V. Usuelli,1 M. Ben Nasr,1,2 F. D'Addio,1,2 L. Kaifeng,2 L. Borgese,3 L. Potena,3 A. Solini,4 C. Rossi,4 A. Secchi,1 D. Corradi,5 N. Chau,6 P. Fiorina.1,2

    1Ospedale San Raffaele, Milano, Italy; 2Boston Children's Hospital, Boston; 3University of Bologna, Bologna, Italy; 4University of Pisa, Pisa, Italy; 5University of Parma, Parma, Italy; 6Regulus Therapeutics Inc, San Diego.

    Background. Heart transplantation is the most effective therapy to prolong life expectancy in patients with end-stage heart failure. However, despite much progress in the field,…
  • 2016 American Transplant Congress

    Urine-Derived Cell Lines as a Novel Tool for Monitoring Allo-Reactivity in Kidney Transplant Patients.

    C. Thieme,1 B. Weist,1 M. Schmück,1 P. Reinke,1 N. Babel.1,2

    1Berlin-Brandenburg Center for Regenerative Therapies, University Medicine Berlin, Berlin, Germany; 2Medical Clinic I, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.

    Reactivity of the immune system against donor antigens determines transplant-rejection after transplantation, and analyzing the alloimmune response has been shown to predict acute rejection in…
  • 2016 American Transplant Congress

    High PD-L1/CD86 MFI Ratio and IL-10 Secretion Characterize Maturation-Resistant Human Regulatory Dendritic Cells (DCregs) Generated for Clinical Testing in Transplantation.

    A. Zahorchak,1 L. Butterfield,2,3 C. Macedo,1 D. Hamm,4 D. Metes,1,3 A. Thomson.1,3

    1Surgery, Thomas E. Starzl Transplantation Institute, Pittsburgh; 2Medicine, University of Pittsburgh, Pittsburgh; 3Immunology, University of Pittsburgh, Pittsgurgh; 4Adaptive Biotech, Seattle.

    Regulatory dendritic cells (DCregs) have shown considerable potential for safe and effective prolongation of allograft survival in pre-clinical models. In humans, DCregs with purity >84%…
  • 2016 American Transplant Congress

    Diabetes Mellitus Predicts Outcome in Obesity After Kidney Transplantation.

    T. Schachtner,1,2 M. Stein,2 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany.

    Obesity has been associated with an increased risk of allograft loss and death from infection in kidney transplant recipients (KTRs). Therefore, previous studies suggested bariatric…
  • 2016 American Transplant Congress

    Allo-Specific Memory B Cell Recall Responses Are Dependent on B Cell Autophagy.

    J. Leventhal,1 M. Fribourg,2 J. Ni,1 P. Heeger.1

    1Medicine, Icahn School of Medicine at Mount Sinai, NY, NY; 2Neurology, Icahn School of Medicine at Mount Sinai, NY, NY.

    B cells, and in particular, memory B cells (Bmem) are sources of donor specific antibodies (DSA) that cause allograft injury. Understanding requirements for Bmem function/survival…
  • 2015 American Transplant Congress

    Host NK Cell Allorecognition of Passenger Donor Lymphocytes Within Allografts Is Essential for Preventing Augmentation of Recipient Adaptive Alloimmunity

    J. Ali, I. Harper, M. Negus, E. Bolton, K. Saeb-Parsy, J. Bradley, G. Pettigrew.

    Department of Surgery, University of Cambridge, Cambridge, United Kingdom.

    Background:Memory T cells are now appreciated to reside in peripheral non-lymphoid tissue, but how their presence within solid organ allografts impacts upon transplant outcomes is…
  • 2015 American Transplant Congress

    Microchimerism-Tolerance “Missing Link”: Exosome Acquisition by Host Dendritic Cells

    W. Bracamonte-Baran, E. Jankowska-Gan, Y. Zhou, W. Burlingham.

    Surgery, University of Wisconsin, Madison, WI.

    Background: widespread maternal microchimerism (MMc) in mice is associated with development of immune regulation, which can be used to predict transplantation tolerance. We recently showed…
  • 2015 American Transplant Congress

    Presence of Donor Leukocytes and Donor MHC-Cross-Dressed Recipient Cells and Its Relationship to Direct T Cell Alloresponses After Allotransplantation

    J. Marino,1 P. Crosby Bertorini,1 M. Uehara,2 J. Paster,1 S. Mordecai,3 W.-H. Liu,1 L. Liu,1 R. Abdi,2 G. Tocco,1 J. Kim,1 J. Markmann,1 G. Benichou.1

    1Surgery Department, Center for Transplantation Sciences, Massachusetts General Hospital / Harvard Medical School, Boston, MA; 2Department of Medicine, Renal Division, Brigham and Women's Hospital, Boston, MA; 3Department of Pathology, Flow and Imaging Cytometry Core, Massachusetts General Hospital, Boston, MA.

    We have studied the kinetics of donor cell trafficking from the graft to recipient's lymphoid organs and its correlation to the direct T cell alloresponse…
  • 2015 American Transplant Congress

    IgM+ Antigen Binding B Cells in Peripheral Blood Regulate IFNγ Production in Response to HLA Proteins

    L. McLaughlin,1 K. Shiu,1 G. Lombardi,1 J. Spencer,2 R. Vaughan,1 A. Dorling.1

    1MRC Centre for Transplantation, King's College London, London, United Kingdom; 2Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.

    Chronic antibody mediated rejection (CAMR) is a major cause of graft loss in renal transplant recipients. Previous work utilising an IFNγ ELISPOT assay revealed two…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences